Need more? Try out  Advanced Search (20+ criteria)»

logo

Last Update

This profile was last updated on 6/12/2017 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Richard Sherman?

Richard L. Sherman

Vice President, Business Development and General Counsel

Hawaii Biotech , Inc.

HQ Phone:  (808) 486-5333

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Hawaii Biotech , Inc.

650 Iwilei Road Suite 204

Honolulu, Hawaii,96817

United States

Company Description

The Company is committed to the development of the highest quality products with superior efficacy as demonstrated through the various stages of clinical trials. We plan to partner and license our vaccine candidates after safety and immunogenicity data has bee...more

Background Information

Employment History

Deputy General Counsel

SmithKline Beckman Corporation


Principal

CIP Capital


Senior Vice President, Secretary and General Counsel

TETRALOGIC PHARMACEUTICALS CORP


Vice President

Malvern Consulting Group , Inc.


Affiliations

Immunomedics , Inc.

Board Member


QED Technologies Inc

Managing Officer


Cyto-Med Inc

Board Member


Functional Technologies Corp

Board Member


Biophage Pharma Inc.

Board Member


Kenna Technologies , Inc.

Board Member


Mera Pharmaceuticals Inc

Board Member


Sparta Pharmaceuticals

Board Member


Bessor Pharma

Business Advisory Board Member


Sbarro Health Research Organization

Board Member


The Children's Hospital of Philadelphia

Technology Advisory Board


University of Hawaii Medical School

Member of the Advisory Board


The Saint Andrew Society of Hawaii

Board Member


Diagenetix Inc

Advisor


Aloha Medical Mission

Board Member


Advisory

Member, Boards of UH Connections, MarBec Marine Sciences Consortium


HiBEAM company

Board Member


Board

Active Member


Pennsylvania Biotechnology Association

Board Member


Crossroads Schools

Member of the Board of Trustees


Hawaii Venture Capital Association

Board Member


Hawaii Science & Technology Council

Board Member


Pennsylvania Bar Association

Member


IBAH , Inc.

Board Member


Leversense LLC

Board Member


Ben Franklin Technology Partners

Member of the Investment Advisory Committee


START Technology Partnership

Executive Board


University of Hawai'i John A. Burns School of Medicine

Advisory Board


Aquasearch , Inc.

Board Member


Education

B.A.

political science and economics

University of Nebraska


JD


Juris Doctor

New York University School of Law


Web References(108 Total References)


hibiotech.com

Richard Sherman, JD
Director, Vice President, Business Development and General Counsel Mr. Sherman has forty years of experience as a licensing executive, attorney, consultant, and venture capitalist in the biotechnology and pharmaceutical industries. He is is Senior Vice President, Secretary and General Counsel of TetraLogic Pharmaceuticals Corporation (TLOG), a public company located in Malvern, Pennsylvania. He is also a principal in a private SBIC Investment fund, CIP Capital, L.P. and a venture partner in the SCP/Vitalife family of funds in suburban Philadelphia. Mr. Sherman spent more than a decade (1976-1989) as Deputy General Counsel of SmithKline Beckman Corporation (now GlaxoSmithKline), was a partner in the law firm of Pepper Hamilton LLP (1990-1992), and was founder and managing officer (1992-2001) of QED Technologies, Inc., a life science business consulting firm purchased in 1999 by The Omnicom Group. Mr. Sherman has served on the Board of Directors of a number of public and private for-profit companies in the U.S. and Canada, including Biophage, Pharma Inc. (BUG), Functional Technologies, Inc., CytoMed, Inc., IBAH, Inc., Kenna Technologies, Inc., Mera Pharmaceuticals, Inc., and Sparta Pharmaceuticals. He is currently a member of the Board of Directors of Immunomedics, Inc. (IMMU).


www.hibiotech.com

Richard Sherman
Richard L. Sherman, JD Vice President, Business Development and General Counsel Mr. Sherman has twenty-five years of experience as a licensing executive, attorney, consultant, and venture capitalist in the biotechnology and pharmaceutical industries. As a licensing executive and Deputy General Counsel in a thirteen year career at SmithKline-Beckman Corporation, Mr. Sherman participated as counsel and negotiator in hundreds of international and domestic transactions; including hostile and friendly acquisitions, divestitures, joint ventures, limited partnerships, research and development collaborations, venture capital investments, joint marketing relationships, distribution arrangements, and licensing transactions. Mr. Sherman also founded QED Technologies, Inc., a consulting firm that provides science-based companies with experienced advice and counsel in developing and implementing strategies to maximize their business and technology assets.


www.scppartners.com [cached]

Richard L. Sherman
SCP Partners The SCP Team Richard L. Sherman Dick Sherman is a Venture Partner with SCP focusing on the life sciences area. Prior to joining SCP, he spent more than a decade (1976-1989) as Deputy General Counsel of SmithKline Beckman Corporation (now GlaxoSmithKline) and was founder and managing officer (1992-2001) of QED Technologies, Inc., a life science business consulting firm that is now a wholly-owned subsidiary of The Omnicom Group in New York. Dick has served on the Board of Directors of CytoMed, Inc., IBAH, Inc., Kenna Technologies, Inc., Mera Pharmaceuticals, Inc., and Sparta Pharmaceuticals. He also serves as Secretary and General Counsel of Hawaii Biotech, Inc., acts as a consultant to the law firm of Goodsill Anderson Quinn & Stifel, in Honolulu, and is a principal in CIP Capital, L.P. Dick is involved in a broad range of life sciences industry activities. He is a Venture Partner of Ventana Global, a venture fund located in Irvine, California, serves as Chairman of Directors at Biophage, Inc., and is a board member of the Sbarro Research Organization. He is also on the Technology Advisory Board for The Children's Hospital of Philadelphia and is a member of the Advisory Board of the University of Hawaii Medical School. Dick graduated magna cum laude from the University of Nebraska (1968), where he was elected to Phi Beta Kappa. He received his J.D. from New York University School of Law in 1971 as a Root-Tilden Scholar. Richard L. Sherman


www.immunomedics.com [cached]

Richard L. Sherman is Senior Vice President, Strategic Transactions and General Counsel of TetraLogic Pharmaceuticals Corporation, a privately held biopharmaceutical company that focuses on the discovery and development of SMAC mimetics, small molecule peptide-mimetic drugs that mimic SMAC (second mitochondrial-derived activator of caspases), for the treatment of cancers and certain other diseases.
Mr. Sherman also serves as a consultant to the law firm of Goodsill Anderson Quinn & Stifel. Prior to joining TetraLogic in 2012, Mr. Sherman provided consulting services to TetraLogic as Vice President, Strategic Partnering and Transactions at Malvern Consulting Group. From 1976 through 1989, Mr. Sherman served as Deputy General Counsel of SmithKline Beckman Corporation (now GlaxoSmithKline). From 1990 through 1992, he was a partner in the law firm of Pepper Hamilton LLP. In addition, from 1992 through 2001, Mr. Sherman was founder and managing officer of QED Technologies, Inc., a life science business consulting firm purchased in 1999 by The Omnicom Group. Mr. Sherman is also a principal in a private SBIC Investment fund, CIP Capital, L.P., and a venture partner in the SCP/Vitalife family of funds in suburban Philadelphia. Mr. Sherman is currently a member of the Board of Directors of Hawaii Biotech, Inc, a privately held company that develops prophylactic vaccines for infectious diseases.


www.hibiotech.com [cached]

Richard Sherman
Richard L. Sherman, J.D. Vice President, Business Development and General Counsel Mr. Sherman has twenty-five years of experience as a licensing executive, attorney, consultant, and venture capitalist in the biotechnology and pharmaceutical industries. As a licensing executive and Deputy General Counsel in a thirteen year career at SmithKline-Beckman Corporation, Mr. Sherman participated as counsel and negotiator in hundreds of international and domestic transactions; including hostile and friendly acquisitions, divestitures, joint ventures, limited partnerships, research and development collaborations, venture capital investments, joint marketing relationships, distribution arrangements, and licensing transactions. Mr. Sherman also founded QED Technologies, Inc., a consulting firm that provides science-based companies with experienced advice and counsel in developing and implementing strategies to maximize their business and technology assets.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory